Heidelberg Pharma (Germany) Performance
| HPHA Stock | EUR 2.35 0.09 3.69% |
The company retains a Market Volatility (i.e., Beta) of -0.72, which attests to possible diversification benefits within a given portfolio. As returns on the market increase, returns on owning Heidelberg Pharma are expected to decrease at a much lower rate. During the bear market, Heidelberg Pharma is likely to outperform the market. At this point, Heidelberg Pharma has a negative expected return of -0.11%. Please make sure to check out Heidelberg Pharma's information ratio, total risk alpha, and the relationship between the coefficient of variation and jensen alpha , to decide if Heidelberg Pharma performance from the past will be repeated at some point in the near future.
Risk-Adjusted Performance
0 of 100
Weak | Strong |
Very Weak
Over the last 90 days Heidelberg Pharma AG has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of latest fragile performance, the Stock's primary indicators remain healthy and the recent disarray on Wall Street may also be a sign of long period gains for the firm investors. ...more
| Begin Period Cash Flow | 5 M | |
| Free Cash Flow | -28 M |
Heidelberg |
Heidelberg Pharma Relative Risk vs. Return Landscape
If you would invest 258.00 in Heidelberg Pharma AG on October 23, 2024 and sell it today you would lose (23.00) from holding Heidelberg Pharma AG or give up 8.91% of portfolio value over 90 days. Heidelberg Pharma AG is generating negative expected returns and assumes 2.9044% volatility on return distribution over the 90 days horizon. Simply put, 25% of stocks are less volatile than Heidelberg, and 99% of all equity instruments are likely to generate higher returns than the company over the next 90 trading days. Expected Return |
| Risk |
Heidelberg Pharma Market Risk Analysis
Today, many novice investors tend to focus exclusively on investment returns with little concern for Heidelberg Pharma's investment risk. Standard deviation is the most common way to measure market volatility of stocks, such as Heidelberg Pharma AG, and traders can use it to determine the average amount a Heidelberg Pharma's price has deviated from the expected return over a period of time. It is calculated by determining the expected price for the established period and then subtracting this figure from each price point. The differences are then squared, summed, and averaged to produce the variance.
Sharpe Ratio = -0.0393
| Best Portfolio | Best Equity | |||
| Good Returns | ||||
| Average Returns | ||||
| Small Returns | ||||
| Cash | Small Risk | Average Risk | High Risk | Huge Risk |
| Negative Returns | HPHA |
Estimated Market Risk
| 2.9 actual daily | 25 75% of assets are more volatile |
Expected Return
| -0.11 actual daily | 0 Most of other assets have higher returns |
Risk-Adjusted Return
| -0.04 actual daily | 0 Most of other assets perform better |
Based on monthly moving average Heidelberg Pharma is not performing at its full potential. However, if added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of Heidelberg Pharma by adding Heidelberg Pharma to a well-diversified portfolio.
Heidelberg Pharma Fundamentals Growth
Heidelberg Stock prices reflect investors' perceptions of the future prospects and financial health of Heidelberg Pharma, and Heidelberg Pharma fundamentals are critical determinants of its market performance. Overall, investors pay close attention to revenue and earnings growth, profit margins, and debt levels. These fundamentals can have a significant impact on Heidelberg Stock performance.
| Current Valuation | 194.72 M | |||
| Price To Book | 24.79 X | |||
| Price To Sales | 12.52 X | |||
| Revenue | 1.75 M | |||
| EBITDA | (24.84 M) | |||
| Cash Flow From Operations | (26.61 M) | |||
| Total Asset | 21.73 M | |||
About Heidelberg Pharma Performance
By examining Heidelberg Pharma's fundamental ratios, stakeholders can obtain critical insights into Heidelberg Pharma's financial health, operational efficiency, and overall profitability. These insights assist in making well-informed investment and management decisions. For example, a high Return on Assets and Return on Equity would indicate that Heidelberg Pharma is effectively utilizing its assets and equity to generate significant profits, enhancing its appeal to investors. On the other hand, low ROA and ROE values could reveal issues in asset and equity management, highlighting the need for operational improvements.
Things to note about Heidelberg Pharma performance evaluation
Checking the ongoing alerts about Heidelberg Pharma for important developments is a great way to find new opportunities for your next move. Stock alerts and notifications screener for Heidelberg Pharma help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.| Heidelberg Pharma generated a negative expected return over the last 90 days | |
| Heidelberg Pharma has a very high chance of going through financial distress in the upcoming years | |
| The company reported the revenue of 1.75 M. Net Loss for the year was (26.14 M) with profit before overhead, payroll, taxes, and interest of 0. | |
| Heidelberg Pharma generates negative cash flow from operations |
- Analyzing Heidelberg Pharma's financial statements, including its income statement, balance sheet, and cash flow statement, helps in understanding its overall financial health and growth potential.
- Getting a closer look at valuation ratios like price-to-earnings (P/E) ratio, price-to-sales (P/S) ratio, and price-to-book (P/B) ratio help in understanding whether Heidelberg Pharma's stock is overvalued or undervalued compared to its peers.
- Examining Heidelberg Pharma's industry or sector and how it is performing can give you an idea of its growth potential and how it is positioned relative to its competitors.
- Evaluating Heidelberg Pharma's management team can have a significant impact on its success or failure. Reviewing the track record and experience of Heidelberg Pharma's management team can help you assess the Company's leadership.
- Pay attention to analyst opinions and ratings of Heidelberg Pharma's stock. These opinions can provide insight into Heidelberg Pharma's potential for growth and whether the stock is currently undervalued or overvalued.
Other Information on Investing in Heidelberg Stock
Heidelberg Pharma financial ratios help investors to determine whether Heidelberg Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Heidelberg with respect to the benefits of owning Heidelberg Pharma security.